CG-223

N/A

Report date: 2023/02/19 22:42:22
NME

Base Information

Drug NameCG-223
Drug Alias NameCG-223
ClassificationSmall molecules
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitorsDopamine D2 receptor antagonists
TargetsBromodomain and extra terminal domain proteinDopamine D2 receptor
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto Prefectural University Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesKyoto Prefectural University Of Medicine
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A